Corient Private Wealth
REGN icon

Corient Private Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

Corient Private Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.78M Sell
12,473
-5,600
-31% -$3.81M 0.01% 722
2026
Q1 		$13.9M Buy
18,073
+1,483
+9% +$1.14M 0.02% 504
2025
Q4 		$12.8M Sell
16,590
-782
-5% -$531K 0.02% 501
2025
Q3 		$9.77M Buy
17,372
+174
+1% +$98.4K 0.02% 525
2025
Q2 		$9.03M Sell
17,198
-4,688
-21% -$2.62M 0.01% 544
2025
Q1 		$13.9M Sell
21,886
-998
-4% -$686K 0.02% 450
2024
Q4 		$16.3M Sell
22,884
-4,349
-16% -$3.65M 0.03% 425
2024
Q3 		$28.6M Buy
27,233
+4,992
+22% +$5.56M 0.04% 350
2024
Q2 		$23.4M Sell
22,241
-12,188
-35% -$11.8M 0.04% 360
2024
Q1 		$33.1M Buy
34,429
+868
+3% +$825K 0.06% 292
2023
Q4 		$29.5M Buy
33,561
+2,537
+8% +$2.09M 0.05% 317
2023
Q3 		$25.5M Buy
31,024
+823
+3% +$647K 0.06% 299
2023
Q2 		$21.7M Sell
30,201
-980
-3% -$756K 0.05% 316
2023
Q1 		$25.6M Buy
31,181
+16,479
+112% +$12.4M 0.07% 268
2022
Q4 		$10.6M Buy
+14,702
New +$10.8M 0.04% 360

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Corient Private Wealth's REGN Position: Q2 2026 in Review

Corient Private Wealth reduced its Regeneron Pharmaceuticals (REGN) stake by 31% in Q2 2026, selling an estimated $3.81M and leaving 12,473 shares worth $7.78M. The position accounts for 0.01% of the portfolio, ranked #722.

Corient Private Wealth first reported a position in REGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $33.1M in Q1 2024. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Corient Private Wealth held 12,473 shares of Regeneron Pharmaceuticals worth $7.78M as of Q2 2026.
  • Corient Private Wealth sold 5,600 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $3.81M.
  • Regeneron Pharmaceuticals made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #722 holding.
  • Corient Private Wealth first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Regeneron Pharmaceuticals position peaked at $33.1M in Q1 2024.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.